Skip to search formSkip to main contentSkip to account menu

Haemophilus influenzae type b-polysaccharide vaccine-diphtheria toxoid conjugate

Known as: Hib-PS-diphtheria toxoid conjugate vaccine, Hib-PS-DT vaccine, Hib (PRP-D) 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1987
1987
We postulate that the affinity of antibody against polyribosylribitol phosphate (PRP) may be as important as concentration in… 
Review
1986
Review
1986
The safety and immunogenicity of an Haemophilus influenzae type b capsular polysaccharide-diphtheria toxoid vaccine (PRP-D) has… 
1985
1985
22 three months old children received three doses of PRP-D at 2 months intervals, and 21 only one dose when 7 months old. In both…